COPD with FEV1 ≥ 50%, Minimal Dyspnoea, and Low Exacerbation Risk — Treatment Approach

This protocol applies to COPD patients in the low-risk category: preserved lung function (FEV1 ≥ 50%), mild or absent dyspnoea (mMRC score 0 or 1), and one or no exacerbation in the previous year without hospitalisation. Despite this favourable profile, these patients have permanent respiratory symptoms that limit daily tasks.

The pharmacological basis for this low-risk COPD patient with persistent symptoms involves a single inhaled long-acting bronchodilator, with guidance on which class to prioritise. The complete protocol specifies the preferred agent class and the full decision pathway.